ALAN WILSON: Open Payments
NPI 1417332081 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 11 payments from 8 companies in 2025. Trend: 2023 $372 · 2024 $369 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $72 |
| La Jolla Pharmaceutical Company | 2 | $55 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Medtronic, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
Products named: GIAPREZA, ZERBAXA, Exparel, TERLIVAZ, SIGNIA, TEFLARO, XIFAXAN, OCALIVA.
Industry payments across TX — which companies pay providers there.
